Profile
Rob Henderson worked as the Director of Product Management at Corixa Corp.
He then served as the Chief Scientific Officer at Viridian Therapeutics, Inc. from 2021 to 2024.
Dr. Henderson obtained his undergraduate degree from the University of Virginia.
Former positions of Rob Henderson
Companies | Position | End |
---|---|---|
VIRIDIAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2023 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | - |
Training of Rob Henderson
University of Virginia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
- Stock Market
- Insiders
- Rob Henderson